Environmental Risk Assessments for Human Medicinal Products – Challenges and Recent Developments

Duration: 1 hour


If you do not wish to receive any communication from us, you may unsubscribe at any time. Click here to view our privacy policy.

Why watch

Key Learnings

  •  The step-wise approach to environmental risk assessment
  •  Calculation of predicted environmental concentration for standard and orphan indications
  •  Possibilities to waive environmental studies

A full day of inspirational speakers

Proud to bring inspirational speakers from across the globe.

Dr. Angela Vogt-Eisele

Senior Manager Scientific Affairs, PharmaLex

Angela has worked for the pharmaceutical industry for over 10 years supporting non-clinical and clinical development programs for human medicinal products. One of her central areas of expertise lies in the field of environmental risk assessments (Europe, USA and world-wide), including development of overall strategy, communication with authorities, project management and study monitoring as well as compilation of the ERA document.